Nature

Outcome of children requiring intensive care following haematopoietic SCT for primary immunodeficiency and other non-malignant disorders

Haematopoietic SCT (HSCT) is curative for many children with primary immunodeficiencies or other non-malignant conditions. Outcome for those admitted to intensive care following HSCT for oncology ...
pharmaphorum

FDA clears Orca's cell therapy Tregzi for GvHD

Orca Bio has become a commercial-stage company with the FDA approval of Tregzi, a cell-based immunotherapy designed to ...
Medscape

Phone-Based Support Improves Well-being After Stem Cell Transplant

A phone-delivered positive psychological intervention for allogeneic hematopoietic stem cell transplant (HSCT) survivors was feasible and showed preliminary efficacy in a pilot randomized clinical ...
Medscape

FDA Approves Orca‑T, a Next‑Gen HSCT to Reduce GVHD

By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.
Nature

HSCT for Crohn's disease: work in progress or a bridge too far?

Haematopoietic stem cell transplantation for refractory Crohn's disease has the potential to halt therapy-resistant inflammation. Hawkey et al. argue that HSCT does not offer sustained benefit based ...
The American Journal of Managed Care

Treosulfan Approval Offers Novel Option for Allo-HSCT Conditioning in AML/MDS

Mikkael A. Sekeres, MD, Sylvester Comprehensive Cancer Center, discusses the potential benefits of treosulfan, a newly approved agent for allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...
The American Journal of Managed Care

Characterizing Patients With MDS Who Undergo Allo-HSCT

MDS patients undergoing allo-HSCT have higher in-hospital mortality and complications, including mechanical ventilation and acute graft-vs-host disease. The proportion of MDS patients receiving ...
Healio

Autologous HSCT effective, safe for older adults with multiple myeloma

Please provide your email address to receive an email when new articles are posted on . Autologous hematopoietic stem cell transplant conferred favorable 2-year outcomes among older adults with ...
Healio

Allogeneic HSCT induces durable response in B-cell lymphoma

Please provide your email address to receive an email when new articles are posted on . “There are currently three FDA approved CAR T-cell therapies targeting the CD19 antigen to treat relapsed or ...
Business Wire

COVID-19 Impacts: Hematopoietic Stem Cells Transplantation (HSCT) Market will Accelerate at a CAGR of Almost 6% Through 2020-2024 | Demand for Personalized Medicine to Boost ...

LONDON--(BUSINESS WIRE)--Technavio has been monitoring the hematopoietic stem cells transplantation (HSCT) market and it is poised to grow by USD 4.64 billion during 2020-2024, progressing at a CAGR ...
ascopubs.org

Safety outcomes in adult patients with AML who achieved their first complete remission with GO prior to HSCT.

RNA expression-based risk stratification of de novo acute myeloid leukemia. Co-mutation landscape and its prognostic impact on newly diagnosed adult patients with NPM1 mutated de novo acute myeloid ...